NUEVOCOR PTE. LTD.
Country of registration | Singapore |
Registration number | 202011115E |
Local SIC | |
Incorporation date | 8 Apr 2020 |
Company age | 6 years 1 month |
Official entity type | Private Limited Company |
No. of officers | 32 |
Contact
1 BIOPOLIS DRIVE, #05-01, AMNIOS, Singapore 138622
This is the legal entity page of NUEVOCOR PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- NUEVOCORView MoreSingaporeNuevocor is a biotech start-up in Singapore focused on developing gene therapies for genetic cardiomyopathies by leveraging advanced cell biology and cutting-edge technology platforms, including novel gene therapy vectors and proteomics-based target discovery.
Auditor | ERNST & YOUNG LLP |
Revenue | < 1m |
Share Capital - Ordinary shares | USD 2,166,661 |
Share Capital - Ordinary shares | SGD 52,969 |
Share Capital - Preference shares | USD 21,833,281 |
Frequently Asked Questions (FAQ)
- What is the address of NUEVOCOR PTE. LTD.?
- Where is NUEVOCOR PTE. LTD.'s headquarter?
- What is NUEVOCOR PTE. LTD.'s contact number?
- What NUEVOCOR PTE. LTD.'s spending power?
- Does NUEVOCOR PTE. LTD. have a presence in the domain it operates in?

